Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 91.40
+0.34 (0.37%)
At close: Feb 13, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 20.88 billion as of February 13, 2026. Its market cap has decreased by -2.41% in one year.
Market Cap
20.88B
Enterprise Value
22.77B
Revenue
13.30B
Ranking
n/a
PE Ratio
23.38
Stock Price
91.40
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 20.88B, an increase of 192.27%. That is a compound annual growth rate of 26.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 20.88B | 8.04% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 132.35B |
| Abbott Laboratories (Pakistan) | 115.67B |
| The Searle Company | 68.56B |
| AGP Limited | 67.61B |
| Highnoon Laboratories | 54.41B |
| Ferozsons Laboratories | 19.45B |
| Macter International | 16.02B |
| Otsuka Pakistan | 4.63B |